270 related articles for article (PubMed ID: 24402308)
21. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
[TBL] [Abstract][Full Text] [Related]
22. Wiskott-Aldrich syndrome.
Notarangelo LD; Miao CH; Ochs HD
Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
[TBL] [Abstract][Full Text] [Related]
23. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
[TBL] [Abstract][Full Text] [Related]
24. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
Blundell MP; Worth A; Bouma G; Thrasher AJ
Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
[TBL] [Abstract][Full Text] [Related]
25. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.
Stewart DM; Tian L; Nelson DL
J Immunol; 1999 Apr; 162(8):5019-24. PubMed ID: 10202051
[TBL] [Abstract][Full Text] [Related]
26. The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton.
Imai K; Nonoyama S; Miki H; Morio T; Fukami K; Zhu Q; Aruffo A; Ochs HD; Yata J; Takenawa T
Clin Immunol; 1999 Aug; 92(2):128-37. PubMed ID: 10444357
[TBL] [Abstract][Full Text] [Related]
27. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
Snapper SB; Rosen FS
Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
[TBL] [Abstract][Full Text] [Related]
28. Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: a human cellular model for Wiskott-Aldrich syndrome.
Toscano MG; Anderson P; Muñoz P; Lucena G; Cobo M; Benabdellah K; Gregory PD; Holmes MC; Martin F
Dis Model Mech; 2013 Mar; 6(2):544-54. PubMed ID: 23324327
[TBL] [Abstract][Full Text] [Related]
29. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
[TBL] [Abstract][Full Text] [Related]
30. Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome.
Sarkar K; Sadhukhan S; Han SS; Vyas YM
Blood; 2014 Nov; 124(23):3409-19. PubMed ID: 25253772
[TBL] [Abstract][Full Text] [Related]
31. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.
Du W; Kumaki S; Uchiyama T; Yachie A; Yeng Looi C; Kawai S; Minegishi M; Ramesh N; Geha RS; Sasahara Y; Tsuchiya S
Hum Mutat; 2006 Apr; 27(4):370-5. PubMed ID: 16511828
[TBL] [Abstract][Full Text] [Related]
32. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
[TBL] [Abstract][Full Text] [Related]
33. Hierarchical regulation of WASP/WAVE proteins.
Padrick SB; Cheng HC; Ismail AM; Panchal SC; Doolittle LK; Kim S; Skehan BM; Umetani J; Brautigam CA; Leong JM; Rosen MK
Mol Cell; 2008 Nov; 32(3):426-38. PubMed ID: 18995840
[TBL] [Abstract][Full Text] [Related]
34. A congenital activating mutant of WASp causes altered plasma membrane topography and adhesion under flow in lymphocytes.
Burns SO; Killock DJ; Moulding DA; Metelo J; Nunes J; Taylor RR; Forge A; Thrasher AJ; Ivetic A
Blood; 2010 Jul; 115(26):5355-65. PubMed ID: 20354175
[TBL] [Abstract][Full Text] [Related]
35. The mouse homolog of the mutant WASp responsible for human X-linked neutropenia renders granulopoiesis ineffective.
Ikeda M; Futami M; Chanda B; Kobayashi M; Izawa K; Tojo A
Biochem Biophys Res Commun; 2022 Sep; 622():177-183. PubMed ID: 35932529
[TBL] [Abstract][Full Text] [Related]
36. Detection of six novel mutations in WASP gene in fifteen Iranian Wiskott-Aldrich patients.
Safaei S; Fazlollahi MR; Houshmand M; Hamidieh AA; Bemanian MH; Alavi S; Mousavi F; Pourpak Z; Moin M
Iran J Allergy Asthma Immunol; 2012 Dec; 11(4):345-8. PubMed ID: 23264413
[TBL] [Abstract][Full Text] [Related]
37. Identification of six novel WASP gene mutations in patients suffering from Wiskott-Aldrich syndrome.
Brooimans RA; van den Berg AJ; Tamminga RY; Revesz T; Wulffraat NM; Zegers BJ
Hum Mutat; 2000 Apr; 15(4):386-7. PubMed ID: 10737997
[TBL] [Abstract][Full Text] [Related]
38. Unraveling the molecular effects of mutation L270P on Wiskkot-Aldrich syndrome protein: insights from molecular dynamics approach.
Palaniappan C; Rao S; Ramalingam R
J Biomol Struct Dyn; 2016 Sep; 34(9):2011-22. PubMed ID: 26457828
[TBL] [Abstract][Full Text] [Related]
39. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
[TBL] [Abstract][Full Text] [Related]
40. Alternative control: what's WASp doing in the nucleus?
Teitell MA
Sci Transl Med; 2010 Jun; 2(37):37ps31. PubMed ID: 20574067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
